Abcam is a producer and distributor of research-grade antibodies and associated products headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japan office located in Tokyo.  Our products cover research areas such as cancer, cardiovascular, chromatin & nuclear signaling, immunology, neuroscience, and stem cells, and includes a growing range of non-primary antibody products such as secondary antibodies, kits, proteins, peptides and lysates.   Our mission is to build the largest online catalog of the best antibodies in the world.

Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness.

Biogen Idec helped create an industry that has touched countless lives. We were among the world's first biotechnology companies, and today we are the oldest independent biotech firm in the world. Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis.

The Broad Institute of MIT and Harvard was founded to transform medicine with genomic knowledge. Its mission is to catalog all of biology at the molecular level, uncover the specific alterations that lead to human disease, and discover new and effective ways to modulate those alterations. To accomplish these ambitious goals, the Broad brings together scientific teams from across traditional institutional and disciplinary boundaries and empowers them with unprecedented technological and scientific resources.